Institutional & Family Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Institutional & Family Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	–	–	828
2022 Q1	$0	Buy	9 +7	+350%	+$235	﹤0.01%	856
2021 Q4	$0	Sell	2 -8	-80%	-$358	﹤0.01%	974
2021 Q3	$1K	Sell	10 -6	-38%	-$427	﹤0.01%	899
2021 Q2	$1K	Hold	16	–	–	﹤0.01%	936
2021 Q1	$2K	Sell	16 -10	-38%	-$1.19K	﹤0.01%	828
2020 Q4	$3K	Sell	26 -1	-4%	-$110	﹤0.01%	737
2020 Q3	$2K	Hold	27	–	–	﹤0.01%	750
2020 Q2	$2K	Buy	+27	New	+$1.56K	﹤0.01%	733

Other funds holding TPTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Institutional & Family Asset Management's TPTX Position: Q2 2022 in Review

Institutional & Family Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2022, closing a stake of 9 shares.

Institutional & Family Asset Management first reported a position in TPTX in Q2 2020 and held it in 8 quarters. The position peaked at $3K in Q4 2020. 208 funds tracked by Wall St. Rank hold TPTX as of Q2 2022.

Institutional & Family Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Institutional & Family Asset Management sold 9 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2022.
Institutional & Family Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Institutional & Family Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $3K in Q4 2020.
208 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Institutional & Family Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.